Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

AMPHOTERICIN B

AMPHOTERICIN B

Standard Dose
50MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AMPHOTERICIN B is listed in Drugs@FDA under application 215354 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AMPHOTERICIN B Form and strength INJECTABLE, LIPOSOMAL;INJECTION - 50MG/VIAL Sponsor AVET LIFESCIENCES Submission history Latest submission status date: 2025-06-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPHOTERICIN B is listed in Drugs@FDA under application 215354 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMPHOTERICIN B Form and strength INJECTABLE, LIPOSOMAL;INJECTION - 50MG/VIAL Sponsor AVET LIFESCIENCES Submission history Latest submission status date: 2025-06-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.